These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8961509)

  • 1. Vaccination protects beta 2 microglobulin deficient mice from immune mediated mortality but not from persisting viral infection.
    Hildeman D; Salvato M; Whitton JL; Muller D
    Vaccine; 1996 Sep; 14(13):1223-9. PubMed ID: 8961509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of lymphocytic choriomeningitis disease in beta 2-microglobulin-deficient mice by CD4+ T cells.
    Quinn DG; Zajac AJ; Frelinger JA; Muller D
    Int Immunol; 1993 Oct; 5(10):1193-8. PubMed ID: 7903551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection.
    Zajac AJ; Quinn DG; Cohen PL; Frelinger JA
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14730-5. PubMed ID: 8962123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
    Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against persistent viral infection exacerbates CD4+ T-cell-mediated immunopathological disease.
    Hildeman D; Yañez D; Pederson K; Havighurst T; Muller D
    J Virol; 1997 Dec; 71(12):9672-8. PubMed ID: 9371632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.
    von Herrath MG; Yokoyama M; Dockter J; Oldstone MB; Whitton JL
    J Virol; 1996 Feb; 70(2):1072-9. PubMed ID: 8551565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice.
    Holst PJ; Christensen JP; Thomsen AR
    J Immunol; 2011 Apr; 186(7):3997-4007. PubMed ID: 21357263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogen influences CD4+ T-lymphocyte activity in vivo and in vitro in beta 2-microglobulin-deficient mice.
    Muller D; Chen M; Vikingsson A; Hildeman D; Pederson K
    Immunology; 1995 Oct; 86(2):162-7. PubMed ID: 7490113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice.
    Muller D; Koller BH; Whitton JL; LaPan KE; Brigman KK; Frelinger JA
    Science; 1992 Mar; 255(5051):1576-8. PubMed ID: 1347959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell activity in lymphocytic choriomeningitis virus-infected beta 2-microglobulin-deficient mice.
    Zajac AJ; Muller D; Pederson K; Frelinger JA; Quinn DG
    Int Immunol; 1995 Oct; 7(10):1545-56. PubMed ID: 8562499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection.
    Klavinskis LS; Whitton JL; Oldstone MB
    J Virol; 1989 Oct; 63(10):4311-6. PubMed ID: 2476571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus Serotype 5 Vaccination Results in Suboptimal CD4 T Helper 1 Responses in Mice.
    Lee J; Hashimoto M; Im SJ; Araki K; Jin HT; Davis CW; Konieczny BT; Spies GA; McElrath MJ; Ahmed R
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28003483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-specific, CD8+ major histocompatibility complex class I-restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus-infected beta2-microglobulin-deficient mice.
    Quinn DG; Zajac AJ; Hioe CE; Frelinger JA
    J Virol; 1997 Nov; 71(11):8392-6. PubMed ID: 9343195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus Vector Vaccination Impacts NK Cell Rheostat Function following Lymphocytic Choriomeningitis Virus Infection.
    Blass E; Aid M; Martinot AJ; Larocca RA; Kang ZH; Badamchi-Zadeh A; Penaloza-MacMaster P; Reeves RK; Barouch DH
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct ex vivo kinetic and phenotypic analyses of CD8(+) T-cell responses induced by DNA immunization.
    Hassett DE; Slifka MK; Zhang J; Whitton JL
    J Virol; 2000 Sep; 74(18):8286-91. PubMed ID: 10954526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus.
    Moskophidis D; Battegay M; van den Broek M; Laine E; Hoffmann-Rohrer U; Zinkernagel RM
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():381-91. PubMed ID: 7531218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen.
    Oehen S; Waldner H; Kündig TM; Hengartner H; Zinkernagel RM
    J Exp Med; 1992 Nov; 176(5):1273-81. PubMed ID: 1402673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes.
    Castrucci MR; Hou S; Doherty PC; Kawaoka Y
    J Virol; 1994 Jun; 68(6):3486-90. PubMed ID: 7514676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication-incompetent rabies virus vector harboring glycoprotein gene of lymphocytic choriomeningitis virus (LCMV) protects mice from LCMV challenge.
    Takayama-Ito M; Lim CK; Yamaguchi Y; Posadas-Herrera G; Kato H; Iizuka I; Islam MT; Morimoto K; Saijo M
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006398. PubMed ID: 29659579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccination against persistent viral infection.
    Martins LP; Lau LL; Asano MS; Ahmed R
    J Virol; 1995 Apr; 69(4):2574-82. PubMed ID: 7884908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.